Herrmann, Inge Katrin https://orcid.org/0000-0002-3018-6796
Wood, Matthew John Andrew https://orcid.org/0000-0002-5436-6011
Fuhrmann, Gregor https://orcid.org/0000-0002-6688-5126
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (181290)
Bundesministerium für Bildung und Forschung (13XP5029A)
Article History
Received: 30 June 2020
Accepted: 17 May 2021
First Online: 1 July 2021
Competing interests
: The authors declare the following competing interests: M.J.A.W. is a cofounder and shareholder of Evox Therapeutics.